Literature DB >> 3533368

The effects of embryonic and fetal exposure to x-ray, microwaves, and ultrasound.

R L Brent.   

Abstract

The term radiation evokes emotional responses both from lay persons and from professionals. Many spokespersons are unfamiliar with radiation biology or the quantitative nature of the risks. Frequently, microwave, ultrasound, and ionizing radiation risks are confused. Although it is impossible to prove no risk for any environmental hazard, it appears that exposure to microwave radiation below the maximal permissible levels present no measurable risk to the embryo. Ultrasound exposure from diagnostic ultrasonographic imaging equipment also is quite innocuous. It is true that continued surveillance and research into potential risks of these low-level exposures should continue, but at present ultrasound not only improves obstetric care but also reduces the necessity of diagnostic x-ray procedures. In the field of ionizing radiation, we have as good a comprehension of the biologic effects and the quantitative maximum risks as of any other environmental hazard. Although the animal and human data support the conclusion that no increases in the incidence of gross congenital malformations, intrauterine growth retardation, or abortion will occur with exposures less than 5 rad, that does not mean that there are definitely no risks to the embryo exposed to lower doses of radiation. Whether there exists a linear or exponential dose-response relationship or a threshold exposure for genetic, carcinogenic, cell-depleting, and life-shortening effects has not been determined. In establishing maximum permissible levels for the embryo at low exposures, refer to Tables 4, 5, 6, 8, and 9. It is obvious that the risks of 1-rad or 5-rad acute exposure are far below the spontaneous risks of the developing embryo because 15 per cent of human embryos abort, 2.7 to 3.0 per cent of human embryos have major malformations, 4 per cent have intrauterine growth retardation, and 8 to 10 per cent have early- or late-onset genetic disease. The maximal risk attributed to a 1-rad exposure, approximately 0.003 per cent, is thousands of times smaller than the spontaneous risks of malformations, abortion, or genetic disease. Thus, the present maximal permissible occupational exposures of 0.5 rem for pregnant women (see Table 10) and 5 rem for medical exposure, are extremely conservative. Medically indicated diagnostic roentgenograms are appropriate for pregnant women, and there is no medical justification for terminating a pregnancy in women exposed to 5 rad or less because of a radiation exposure.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3533368

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  7 in total

1.  Effects of ultrasound, shortwaves, and physical exertion on pregnancy outcome in physiotherapists.

Authors:  H Taskinen; P Kyyrönen; K Hemminki
Journal:  J Epidemiol Community Health       Date:  1990-09       Impact factor: 3.710

Review 2.  "Doctor, will that x-ray harm my unborn child?".

Authors:  Savithiri Ratnapalan; Yedidia Bentur; Gideon Koren
Journal:  CMAJ       Date:  2008-12-02       Impact factor: 8.262

3.  In utero exposure to therapeutic radiation for Hodgkin lymphoma.

Authors:  Chagit Klieger-Grossmann; Nada Djokanovic; David Chitayat; Gideon Koren
Journal:  Can Fam Physician       Date:  2009-10       Impact factor: 3.275

4.  The accident at Chernobyl and outcome of pregnancy in Finland.

Authors:  T Harjulehto; T Aro; H Rita; T Rytömaa; L Saxén
Journal:  BMJ       Date:  1989-04-15

5.  Conceptions on genetics in a group of college students.

Authors:  Patrícia Santana Correia; Pedro Vitiello; Maria Helena Cabral de Almeida Cardoso; Dafne Dain Gandelman Horovitz
Journal:  J Community Genet       Date:  2012-11-01

Review 6.  Radiation embryology.

Authors:  C Michel
Journal:  Experientia       Date:  1989-01-15

7.  Obstructing adenocarcinoma of the descending colon in a 31-year-old pregnant woman.

Authors:  Marko Kraljević; Henry Hoffmann; Alexandra Knipprath; Urs von Holzen
Journal:  Int J Surg Case Rep       Date:  2014-10-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.